![](/img/cover-not-exists.png)
Rituximab as a Preconditioning for Kidney Transplant Recipients Also Reduces Incidence of Acute T-Cell Mediated Rejection.
Hirose, T., Tanabe, T., Iwami, D., Morita, K., Sasaki, H., Oishi, Y., Nonomura, K.Volume:
98
Language:
english
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-01490
Date:
July, 2014
File:
PDF, 179 KB
english, 2014